US health regulators have given permission to Covid vaccination that was paused due to worries over blood clotting. Yes here we are talking about Johnson & Johnson Covid vaccinations. On Friday, US authorities allowed permission to restart. Here it is to be noted that health authorities in the United States on April 14 proposed a halt on the vaccine following instances of severe blood clots among a handful of the millions of Americans who received the vaccine.

For your information let us share here that this news came shortly after an expert panel recommended lifting the pause because the shots benefits exceeded possible dangers. Janet Woodcock, head of Food and Drug Administration in a joint statement with the Centers for Disease Control and Prevention (CDC) said that "We have concluded that the known and potential benefits of the Janssen Covid-19 vaccine outweigh its known and potential risks in individuals 18 years of age and older,".

However, To be noted that CDC head Rochelle Walensky said "exceptionally rare events" of clotting were identified, adding that regulators will continue to monitor the rollout of the vaccines. According to data presented Friday, of 3.9 million women who got the Johnson & Johnson shot, 15 developed serious blood clots and three died.

Australian PM Scott Morrison expresses solidarity to India amid COVID-19 surge

Southeast Asian leaders meet over raising issue of Myanmar Violence, says this

Immunologist discovers more potent new airborne Covid strain in Sri Lanka

Covid-19: Nepal seeks India for providing medical supplies to fight COVID-19